BRAF and thyroid nodule: In fact, immunohistochemical markers such as galectin-3, HBME-1 (Hector Battifora’s “Mesothelioma” 1), BRAF V600E, and p53 have been shown to be helpful in the diagnostic phase of thyroid nodules, particularly in distinguishing benign from malignant lesions.